Boston Scientific Corp

Healthcare · Medical Devices

44.90$ +2.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Boston Scientific Corp (BSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 45,216 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BSX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	34,043	35,136	36,669	37,108	38,078	39,395	40,140	41,559	42,707	43,673	44,351	45,216
Current Assets	6,504	6,514	8,185	8,991	8,761	6,920	7,335	7,121	8,035	8,794	8,684	7,972
Cash	952	865	2,329	2,913	2,502	414	725	534	1,275	2,045	1,524	539
Cash & Short-Term Investments	952	865	2,329	2,913	2,502	414	725	534	1,275	2,045	1,524	539
Receivables	2,101	2,228	2,304	2,400	2,501	2,558	2,693	2,815	2,828	2,926	3,027	3,049
Inventory	2,404	2,484	2,561	2,608	2,753	2,810	2,867	2,861	2,921	2,944	3,117	3,235
Property, Plant & Equipment	3,081	–	–	–	3,498	3,743	3,837	3,953	4,290	4,501	–	–
Goodwill	13,608	14,387	14,361	14,397	15,033	17,089	17,340	18,076	18,214	18,282	18,536	18,640
Intangible Assets	5,850	6,003	5,837	5,417	5,754	6,684	6,565	7,259	7,161	7,019	7,060	6,918
Total Liabilities	14,914	15,606	16,501	16,498	17,122	17,392	17,694	18,906	19,077	19,201	18,247	20,044
Current Liabilities	4,579	4,933	4,916	5,576	5,910	6,399	5,058	5,190	5,328	5,439	4,571	6,428
Short-Term Debt	513	531	1,085	1,580	1,652	1,778	777	480	483	389	41	1,709
Accounts Payable	929	942	921	906	907	960	1,004	962	1,002	1,144	1,141	1,231
Long-Term Debt	8,386	8,566	9,530	8,987	9,229	8,842	10,406	10,981	10,993	11,137	10,864	10,791
Shareholders' Equity	18,885	19,281	19,925	20,371	20,708	21,770	22,212	22,418	23,395	24,233	25,864	24,930
Retained Earnings	315	819	1,314	1,639	2,107	2,673	3,347	4,144	4,899	5,571	6,912	7,818
Shares Outstanding	1,475	1,477	1,482	1,484	1,487	1,490	1,493	1,493	1,496	1,496	1,495	1,485

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings